[¹⁸F]FDG

Clinical Evaluation	Glucose metabolism
Type of Imaging	PET
Grade of Recommendation	A (strongly recommended)
Level of Evidence	well-established clinical and NM recommendations recommendations
Effective Dose	19.0 µSv/MBq
Bibliographic Reference	Fizazi, K. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015; https://doi.org... read more Fizazi, K. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015; https://doi.org/10.1093/annonc/mdv305 Losa, F., SEOM clinical guideline on unknown primary cancer. Clin Transl Oncol, 2017; https://doi.org/10.1007/s12094-017-1807-y read less
Guide to Nuclear Medicine	Read the corresponding chapter

Clinical Evaluation
Glucose metabolism
Type of Imaging
PET
Grade of Recommendation
A (strongly recommended)
Level of Evidence
well-established clinical and NM recommendations recommendations
Effective Dose
19.0 µSv/MBq
Bibliographic Reference
Fizazi, K. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015; https://doi.org... read more Fizazi, K. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015; https://doi.org/10.1093/annonc/mdv305 Losa, F., SEOM clinical guideline on unknown primary cancer. Clin Transl Oncol, 2017; https://doi.org/10.1007/s12094-017-1807-y read less
Guide to Nuclear Medicine
Read the corresponding chapter

[18F]FDG